Intelligent Investor

CathRx Ltd (ASX: CXD) - Announcements

DELISTED - Current share price for CXD : $0.007

ASX company news and announcements for CathRx Ltd (CXD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CathRx Ltd (CXD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CathRx Ltd (CXD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CathRx Ltd (CXD)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Appendix 4C - monthly 16 Jan 2008 4:10PM n/a $0.007 $0.007 n/a
- Acquires Patent from Sydney West Area Health Service 5 Nov 2007 8:43AM $2.850 $0.007 $0.007 fallen by 99.75%
- Announces Plans for New Facility 2 Nov 2007 11:35AM $2.850 $0.007 $0.007 fallen by 99.75%
- Appendix 4C - quarterly 29 Oct 2007 4:22PM $2.850 $0.007 $0.007 fallen by 99.75%
- Receives CE Marking for Deflectable Diagnostic Catheters 21 Sep 2007 1:17PM $2.500 $0.007 $0.007 fallen by 99.72%
- Preliminary Final Report 31 Aug 2007 4:39PM $2.250 $0.007 $0.007 fallen by 99.69%
- Renounceable Issue 3 Aug 2007 5:14PM $2.200 $0.007 $0.007 fallen by 99.68%
- Appendix 4C - quarterly 31 Jul 2007 4:06PM $2.400 $0.007 $0.007 fallen by 99.71%
- Commitments Test Entity - Third Quarter Report 27 Apr 2007 4:01PM $2.400 $0.007 $0.007 fallen by 99.71%
- Files for CE Mark for Deflectable Diagnostic Catheters 4 Apr 2007 10:10AM n/a $0.007 $0.007 n/a
- Half Yearly Report/Half Year Accounts 22 Feb 2007 3:59PM n/a $0.007 $0.007 n/a
- Commitments Test Entity - Second Quarter Report 30 Jan 2007 2:58PM $2.400 $0.007 $0.007 fallen by 99.71%
- Receives CE Marking for Cardiac Diagnostic Catheters 22 Dec 2006 12:23PM $2.450 $0.007 $0.007 fallen by 99.71%
- Appoints Distributor in Germany & Austria 12 Dec 2006 10:25AM $2.380 $0.007 $0.007 fallen by 99.71%
- Positive notification of status of European Approvals 11 Dec 2006 8:33AM $2.400 $0.007 $0.007 fallen by 99.71%
- Commitments Test Entity - First Quarter Report 23 Oct 2006 8:30AM $1.700 $0.007 $0.007 fallen by 99.59%
- Preliminary Final Report 13 Sep 2006 8:29AM n/a $0.007 $0.007 n/a
- Commitments Test Entity - Fourth Quarter Report 31 Jul 2006 2:44PM n/a $0.007 $0.007 n/a
- Appoints TOP Medical as Distributor in Benelux Countries 30 Jun 2006 9:58AM $1.600 $0.007 $0.007 fallen by 99.56%
- Positive Assessment of Section of Design Dossier for CE Mark 15 May 2006 9:06AM n/a $0.007 $0.007 n/a
- Commitments Test Entity - Third Quarter Report 26 Apr 2006 11:23AM n/a $0.007 $0.007 n/a
- Appoints Manta as Distributor in Italy 18 Apr 2006 9:11AM $1.650 $0.007 $0.007 fallen by 99.58%
- Files For TGA Approval -Modular Cardiac Diagnostic Catheters 28 Mar 2006 5:04PM $1.650 $0.007 $0.007 fallen by 99.58%
- CathRx Files for CE Mark for Cardiac Diagnostic Catheters 1 Mar 2006 10:07AM n/a $0.007 $0.007 n/a
- Half Yearly Report & Accounts 15 Feb 2006 3:09PM n/a $0.007 $0.007 n/a

76 - 100 of 103 results

Page 4 of 5

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.